Main cMRI parameters at 30 days after STEMI.

<div><p>Background</p><p>Ticagrelor has many protective cardiovascular properties beyond potent antiplatelet action. This study aimed to compare the effects of ticagrelor versus clopidogrel on infarcted mass, quantified by cardiac magnetic resonance (CMR), in patients with ST...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Francisco A Fonseca (16298537) (author)
مؤلفون آخرون:	Adriano Caixeta (634383) (author), Gilberto Szarf (4705714) (author), Ibraim Pinto (4705735) (author), Antonio M Figueiredo Neto (22505150) (author), Carolina N França (16298555) (author), Henrique T Bianco (16298558) (author), Henrique A Fonseca (16298540) (author), Amanda S Bacchin (16301528) (author), Michelle Birtche (22505153) (author), Igor R M Batista (22505156) (author), Maria C Izar (16298579) (author)
منشور في:	2025
الموضوعات:	Biochemistry Medicine Cell Biology Genetics Biotechnology Ecology Developmental Biology Cancer Science Policy Infectious Diseases standard lipid panel reactive protein levels percutaneous coronary interventions means algorithm displayed centralized computerized system cardiac magnetic resonance smaller infarct size myocardial blush ). first 24 hours receive either ticagrelor better lvef among smaller infarcted mass xlink "> ticagrelor ticagrelor versus clopidogrel xlink "> infarcted mass smaller percentage first day 225 ). ticagrelor vs weekly basis underwent angiography timi flow syntax score symptom onset study aimed sensitivity troponin sensitivity c samples collected randomly assigned invasive strategy invasive procedures inflammatory parameters homogeneous responses gensini score culprit artery clopidogrel using 30 days
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Main cMRI parameters at 30 days after STEMI.

مواد مشابهة